Instruction for use: Phagogin Gel with bacteriophages

Dosage form: Gel for topical application

Pharmacological group:

Vaccines, serums, phages and toxoids

The nosological classification (ICD-10)

N39.0 Urinary tract infection without established localization: Fungal infections of the urinary tract; Asymptomatic bacteriuria; Bacterial infections of the urinary tract; Bacterial infections of the urinary tract; Bacterial infections of the genitourinary system; Bacteriuria; Bacteriuria asymptomatic; Bacteriuria chronic latent; Asymptomatic bacteriuria; Asymptomatic massive bacteriuria; Inflammatory urinary tract disease; Inflammatory urinary tract disease; Inflammatory diseases of the bladder and urinary tract; Inflammatory diseases of the urinary system; Inflammatory diseases of the urinary tract; Inflammatory diseases of the urogenital system; Fungal diseases of the urogenital tract; Urinary Tract Infections; Urinary Tract Infections; Infections of the urinary system; Urinary tract infections; Urinary Tract Infections; Urinary tract infections caused by enterococci or mixed flora; Urinary tract infections uncomplicated; Urinary tract infections complicated; Infections of the urogenital system; Infections urogenital; Infectious diseases of the urinary tract; Urinary Tract Infection; Urinary tract infection; Urinary system infection; Urinary tract infection; Urinary tract infection; Infection of the urogenital tract; Uncomplicated urinary tract infections; Uncomplicated urinary tract infections; Uncomplicated urinary tract infections; Uncomplicated infections of the genitourinary system; Exacerbation of chronic urinary tract infection; Retrograde kidney infection; Recurrent urinary tract infections; Recurrent urinary tract infections; Recurrent infectious diseases of the urinary tract; Mixed urethral infections; Urogenital infection; Urogenital Infectious-Inflammatory Disease; Urogenital mycoplasmosis; Urologic disease of infectious etiology; Chronic urinary tract infection; Chronic inflammatory diseases of the pelvic organs; Chronic urinary tract infections; Chronic infectious diseases of the urinary system

N49.9 Inflammatory diseases of unspecified male sexual organ: Infection of genital organs

N73.9 Inflammatory diseases of female pelvic organs, unspecified: Urogenital tract infections; Abscess of pelvic organs; Bacterial diseases of the urogenital tract; Bacterial infections of the genitourinary system; Bacterial infections of the pelvic organs; Intraluminal infections; Inflammation in the area of throat of the uterus; Inflammation of the organs of the small pelvis; Inflammatory disease of the pelvic organs; Inflammatory gynecological diseases; Inflammatory diseases of female pelvic organs; Inflammatory diseases of the pelvic organs; Inflammatory diseases of pelvic organs; Inflammatory infections in the pelvis; Inflammatory processes in the pelvis; Gynecological infection; Gynecological infections; Gynecological infectious diseases; Pyoinflammatory diseases of the pelvic organs; Infections of female genital organs; Infections of the pelvic organs in women; Infections of the pelvic organs; Infectious diseases of the reproductive system; Infectious diseases of genital organs; Infection of female genital organs; Metritis; Acute infection of female genital organs; Acute pelvic inflammatory disease; Tubo-ovarian inflammation; Chlamydial gynecological infections; Chronic inflammatory diseases of the pelvic organs; Chronic inflammatory diseases of appendages; Chronic infections of female genital organs; Pelvic infection

Composition

Gel for topical use 1 fl.

active substance: Sterile suspension of phage particles in physiological solution

Auxiliary substances: purified water; Carbopol; Marigold extract

Pharmachologic effect

Mode of action - Antibacterial.

Dosing and Administration

Locally. At home Phagogin is applied to intimate parts of the body. Phagogin should not be rinsed for 40 minutes after application.

In conditions of admission by a specialist, the affected or injured parts of intimate organs after treatment or surgical procedures are treated with Phagogin.

Do not introduce Phagogin into closed foci of inflammation, not having or having a limited outflow of exudates from the hearth (for example, sutured wounds). The introduction of Phagogin into such foci can lead to marked exacerbation of the inflammatory process and / or edema and / or lymphostasis.

Schemes of application

Day-to-day care of intimate organs in healthy people, incl. With the aim of normalizing the microflora, protecting against harmful environmental influences, preventing sexually transmitted infections (before and after intimacy): 5-7 ml of phagogine (5-7 clicks) 1-2 times a day after hygiene. The length of use of phagogin for preventive purposes is not limited.

Hygiene, prevention of bacterial infections of organs of the intimate sphere in the presence of risk factors, incl. Diabetes mellitus, oncological diseases (especially during radiation and chemotherapy), reduced local and general immunity, fungal and viral infections, genital tract diseases (eg, female genitalia), autoimmune and other systemic diseases: 5-7 ml of phagogine (5 -7 clicks) 2-3 times a day after hygiene measures. The duration of the course corresponds to the duration of the risk factor. If the risk factor is terminated, a regimen for everyday care is recommended.

Prevention of bacterial infections in various types of lesions, including. Erosions, injuries: 5-7 ml of phagogine (5-7 clicks) 2-3 times a day after hygiene measures until the signs of bacterial inflammation disappear in the lesion and / or clinical symptoms. Next, a scheme for everyday care is recommended.

Prevention of bacterial infections of organs of the intimate sphere for sexually transmitted diseases: 5-7 ml of phagogine (5-7 clicks) are applied 2-3 times a day after hygienic measures until the signs of lesions and / or clinical symptoms disappear. Next, a scheme for everyday care is recommended.

Prevention of bacterial inflammatory diseases of organs of the intimate sphere and their relapses, incl. Vaginitis, colpitis, bacterial vaginosis, cervicitis, endometritis, nonspecific exo- and endocervicitis: the dose of phagogin is determined by the doctor based on a specific clinical situation. Phagogin is applied after hygienic treatment and medical manipulation until the signs of clinical symptoms disappear. It is recommended to combine it with home use - 5-7 ml of phagogine (5-7 strokes) 2-3 times a day after hygienic measures. Frequency and duration of application of Phagogin - on the recommendation of a doctor. At the end of the course, a regimen for everyday care is recommended.

Prevention of bacterial complications in obstetrics and gynecology, incl. With complications in the postpartum period (eg postpartum endometritis): the dose of Fagogin is determined by the doctor, based on a specific clinical situation. Phagogin is applied after hygienic treatment and medical manipulation until the signs of bacterial inflammation disappear. It is recommended to combine it with home use - 5-7 ml of phagogine (5-7 clicks) 2-3 times a day after hygienic measures. Frequency and duration of application of Phagogin - on the recommendation of a doctor. At the end of the course, a regimen for everyday care is recommended.

Prevention of bacterial complications in surgical interventions and other therapeutic manipulations in the field of intimate organs: before surgery - at least 5 ml (5 clicks) within 7 days after hygiene. After surgery - at least 5 ml (5 clicks) within 7 days after hygiene measures. At the end of the course, a regimen for everyday care is recommended.

On the prescription of the doctor in other clinical situations in which it is important to provide high antibacterial protection and the absence of side effects: the doctor determines the scheme of application, the frequency and amount of use of phagogin based on a specific clinical situation.

At the initial stage, in the presence of an inflammatory focus, more frequent use of phagogine is recommended at intervals of 1-2 hours until the disappearance of clinical symptoms and pain. The doctor can change the scheme of application, the frequency and the amount of use of Phagogin, based on a specific clinical situation.

Release Form

Gel for topical application. In the bottle 50 ml with a dispenser and protective cap.

Manufacturer

LLC "NEC Agrovetzashchita S.-P." 141315, Russia, Moscow region.; On request of NPC "MicroMir". 107031, Russia, Moscow.

Requisites of the organization authorized to accept claims from consumers: OOO NPC "MicroMir".

Storage conditions of the drug Phagogin Gel with bacteriophages

In a dry, the dark place at a temperature of 2-8 ° C. After the beginning of use it is allowed to store Phagogin at room temperature (not more than 25 ° C) under conditions of sterility and use of the entire contents of the vial for 60 days. The preferred storage location for Phagogin is a refrigerator.

Keep out of the reach of children.

Shelf life of the drug Phagogin Gel with bacteriophages

24 months.

Do not use after the expiry date printed on the package.